A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

Clinical trial NCT07035769 · RECRUITING

Trial details

NCT number: NCT07035769
Sponsor: Debiopharm International SA
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-06-18
Primary completion: 2026-10-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.